Cas no 1565712-50-6 (2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde)
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde
- SY236845
-
- MDL: MFCD26843607
- Inchi: 1S/C7H6F2N2O2/c8-6(9)4-13-7-10-1-5(3-12)2-11-7/h1-3,6H,4H2
- InChI Key: YGXNVYRYPBDKPA-UHFFFAOYSA-N
- SMILES: FC(COC1N=CC(C=O)=CN=1)F
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 13
- Rotatable Bond Count: 4
- Complexity: 161
- Topological Polar Surface Area: 52.1
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y16075-1g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95% | 1g |
¥6759.0 | 2024-07-18 | |
| Apollo Scientific | PC510359-250mg |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95% | 250mg |
£538.00 | 2025-02-21 | |
| Apollo Scientific | PC510359-1g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95% | 1g |
£768.00 | 2025-02-21 | |
| eNovation Chemicals LLC | D685289-0.25g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95% | 0.25g |
$390 | 2024-07-20 | |
| eNovation Chemicals LLC | D685289-1g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95% | 1g |
$605 | 2024-07-20 | |
| Chemenu | CM386645-1g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde |
1565712-50-6 | 95%+ | 1g |
$670 | 2023-02-02 | |
| abcr | AB533394-250 mg |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde; . |
1565712-50-6 | 250MG |
€626.20 | 2023-01-03 | ||
| abcr | AB533394-1 g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde; . |
1565712-50-6 | 1g |
€938.50 | 2023-01-03 | ||
| abcr | AB533394-250mg |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde; . |
1565712-50-6 | 250mg |
€477.70 | 2025-04-20 | ||
| abcr | AB533394-1g |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde; . |
1565712-50-6 | 1g |
€957.40 | 2025-04-20 |
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde Related Literature
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
Additional information on 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde
Introduction to 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde (CAS No. 1565712-50-6)
2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, identified by its unique Chemical Abstracts Service (CAS) number 1565712-50-6, represents a class of pyrimidine derivatives that are widely explored for their potential biological activities. The structural framework of this molecule incorporates a difluoroethoxy group and an aldehyde functionality at the 5-position of the pyrimidine ring, which together contribute to its distinct chemical properties and reactivity. Such structural features make it a valuable intermediate in the synthesis of various pharmacologically relevant molecules.
The pyrimidine core is a fundamental scaffold in biochemistry, serving as a key component in nucleic acids and numerous natural products. Derivatives of pyrimidine have been extensively studied for their roles in enzyme inhibition, receptor binding, and modulation of cellular pathways. In particular, the introduction of fluorine atoms into aromatic rings, as seen in this compound, is a common strategy to enhance metabolic stability, improve binding affinity, and modulate pharmacokinetic profiles. The aldehyde group at the 5-position further extends the synthetic utility of this compound, enabling further functionalization through condensation reactions, oxidation processes, or nucleophilic additions.
Recent advancements in medicinal chemistry have highlighted the importance of difluoroethoxy-substituted compounds due to their ability to influence molecular interactions at the atomic level. The electron-withdrawing nature of fluorine atoms can alter the electronic distribution within the molecule, thereby affecting its solubility, lipophilicity, and reactivity. This has led to increased interest in exploring such derivatives as lead compounds for drug discovery initiatives. The aldehyde functionality, on the other hand, serves as a versatile handle for chemical modifications, allowing chemists to attach diverse molecular fragments or explore new synthetic pathways.
In the context of current research, 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde has been investigated for its potential applications in oncology and anti-inflammatory therapies. Pyrimidine-based molecules are known to interact with biological targets such as kinases and transcription factors, which are often dysregulated in diseases like cancer. The presence of both fluorine substituents and an aldehyde group provides multiple opportunities for designing molecules with enhanced specificity and efficacy. For instance, fluorinated pyrimidines have shown promise in developing kinase inhibitors due to their ability to mimic natural substrates while maintaining improved pharmacological properties.
Moreover, the aldehyde moiety allows for further derivatization into Schiff bases or heterocyclic compounds, which are known to exhibit diverse biological activities. Schiff base formation involves condensation between an aldehyde and an amine group, resulting in imine linkages that can be further functionalized. Such derivatives have been explored for their antimicrobial, anti-inflammatory, and anticancer properties. The combination of these features makes 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde a compelling candidate for further investigation.
Recent studies have also demonstrated the utility of this compound in synthetic chemistry as a building block for more complex molecules. The pyrimidine core can serve as a platform for constructing polycyclic structures or incorporating additional pharmacophores through cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These transformations enable the creation of novel heterocycles with tailored biological activities. Additionally, the presence of fluorine atoms can influence computational modeling studies by affecting electronic properties and intermolecular interactions.
The synthesis of 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde typically involves multi-step organic transformations starting from commercially available precursors. Key steps often include halogenation followed by nucleophilic substitution with fluorinated ethers or Grignard reagents. The introduction of the aldehyde group is commonly achieved through oxidation reactions or formylation processes. Advances in catalytic methods have enabled more efficient and sustainable synthetic routes, reducing waste generation and improving yields.
In conclusion, 2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde (CAS No. 1565712-50-6) represents a structurally interesting compound with significant potential in pharmaceutical research. Its unique combination of substituents—namely the difluoroethoxy group and the aldehyde functionality—makes it a versatile intermediate for drug discovery efforts targeting various diseases. Ongoing research continues to uncover new synthetic strategies and biological applications for this molecule and its derivatives.
1565712-50-6 (2-(2,2-Difluoroethoxy)pyrimidine-5-carbaldehyde) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)